Skip to main content
. Author manuscript; available in PMC: 2020 Nov 1.
Published in final edited form as: Gynecol Oncol. 2019 Aug 30;155(2):324–330. doi: 10.1016/j.ygyno.2019.08.021

Figure 4. A subgroup of the 22 SAAs associate with clinical and pathological features of cervical cancer.

Figure 4.

Expression of chk1_pS345 (A), cjun_pS73 (B), N-cadherin (C), cyclin D1 (D), accl (E), and her3_pY1298 (F) associated with HPV clade, while expression of rad51 (G) associated with cervical cancer stage.